Pediatric ALLNCT04321200
PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
An observational study of Pediatric ALL and Infant Development, run by University of Pennsylvania at 1 site in United States.
Trial summary
Early childhood detection of motor delays or impairments provides the opportunity for early treatment which improves health outcomes. This study will use state of the art sensors combined with machine learning algorithms to develop objective, accurate, easy-to-use tools for the early scoring of deficits and lays the… Read more about this study
- Who is it for?
- Ages 0 to 6 monthsHealthy volunteers can take part
- Conditions the study is for
- Pediatric ALL, Infant Development, Neurodevelopmental Disorders
- What is being tested?
- PANDA Gym and Mobile App
- How many people
- 166 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Nov 2020to 27 Oct 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 0 to 6 months
- All sexes
- Healthy volunteers accepted
- Child
Study population: Study 1: 150 infants (75 with early brain injury, 75 Control). Age 1-6 months. Study 2: 50 infants (25 with early brain injury, 25 Control). Age 1 month. Study 3: 1200 infants (400 with EBI, 400 preterm without EBI/risk for future disability, 400 controls) from video data. Age 1-6 months. Infants without EBI/risk for future disability: Infants without known brain injuries, but with a history of preterm birth less than 32 week gestation, significant medical problems, difficulty eating, or who lack head control at 4 months of age or later will be classified as moderate risk.
Infants, male and female, between 0-6 months (Infants older than 6 months before initial enrollment will be excluded).
- Infants with early brain injury (EBI):
- Hydrocephalus
- Hypoxic-ischemic encephalopathy (HIE)
- Periventricular leukomalacia (PVL)
- Intraventricular hemorrhage (IVH)
- Stroke
- Healthy infants (controls):
- No history of early brain injury (EBI)
- Infants without EBI/risk for future disability:
- Infants without known brain injuries, but with a history of preterm birth less than 32-week gestation with significant medical problems, difficulty eating, or who lack head control at 4 months of age or later will be classified as moderate risk.
Trial locations and contacts
1 site in 1 country.
United States1 site
Childrens Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104
About this study
Official title: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
Early childhood detection of motor delays or impairments provides the opportunity for early treatment which improves health outcomes. This study will use state of the art sensors combined with machine learning algorithms to develop objective, accurate, easy-to-use tools for the early scoring of deficits and lays the foundation for the early prediction of physical disability.
Read the detailed description
For children with neurodevelopmental disabilities, early treatment in the first year of life improves long-term outcomes. However, the investigators are currently held back by inadequacies of available clinical tests to measure and predict impairment. Existing tests are hard to administer, require specialized training, and have limited long-term predictive value. There is a critical need to develop an objective, accurate, easy-to-use tool for the early prediction of long-term physical disability. The field of pediatrics and infant development would greatly benefit from a quantitative score that would correlate with existing clinical measures used today to detect movement impairments in very young infants. To realize a new generation of tests that will be easy to administer, the investigators will obtain large datasets of infants playing in an instrumented gym or simply being recorded while moving in a supine posture. Video and sensor data analyses will convert movement into feature vectors based on our knowledge of the problem domain. Our approach will use machine learning to relate these feature vectors to currently recommended clinical tests or other ground truth information. The power of this design is that algorithms can utilize many aspects of movement to produce the relevant scores.
- Being tested
- PANDA Gym, Mobile App
- Keywords
- Infants, Neurodevelopment, Developmental Delays, Electronics, Early Intervention, Sensory and Motor, NICU, Natural Play
- Medical subject headings
- Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neurodevelopmental Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PANDA GymDiagnostic test
Infants will lie supine on a flat surface and will be placed in the PANDA gym where they either move by themselves or will interact with an instrumented toy. We will collect video, mat, and toy data from PANDA gym under two conditions: 1) infants playing supine without a toy and 2) infants reach, grasp and kick of the new PANDA toy. A test session will proceed as follows: The infant will be placed on his or her back at a predetermined position on the gym mat for the 2-minute no toy condition. Next, the toy will be given to the baby and adjusted for the infant to reach or kick. A caregiver will be seated at the head of the baby (out of a baby's sight) to provide comfort if needed. Testing will be done in NICU or at daycare or the rehabilitation robotics lab at University of Pennsylvania.
Mobile AppOther
The parent or legal guardian will be consented first via the virtual rounding mobile app. They will also be asked to fill out general surveys including, a demographic survey, and a case report form, and a user feedback survey that provides relevant information, on both the family's and infant's medical history and experience. (see the flow-chart for the app). Within the caregiver survey, we will request the pediatrician (or primary care physician) name. We believe that with the baby name, caregiver name, zip code, and physician name, we will be able to locate the physician if needed.
Parents or legal guardians or the research will be asked to collect video via the MOBILE app. They will be instructed to ensure that the infant lies supine in no more than one-layer of tight-fitting clothing (i.e. infant onesie) while calm and awake. In all cases, we will have video recordings of the baby. They will be asked to upload the video to the app.
| Study group | Role | What they receive |
|---|---|---|
| Cross-sectional-150 infants (atypical vs typical) | Arm (Study)1: To assess the concurrent validity of a multimodal instrumented gym with existing clinical tools. Here, using 150 infants, we will focus on converting data from an instrumented gym into estimates of the standard clinical tests. Receives: Diagnostic Test: PANDA Gym | |
| Longitudinal cohort - 50 infants (atypical vs typical) | Arm (Study) 2: To discover the features related to long-term motor development. Here we will convert data collected longitudinally from 50 infants, using both instrumented gym and video recordings, into estimates standard clinical tests change over time and track features over developmental timescales. Receives: Diagnostic Test: PANDA Gym | |
| Cross-sectional-1500 infants (atypical vs typical) | Arm (Study) 3: To develop a computer vision-based algorithm to quantify infant motor performance from a single-camera video. Here using video data from 1200 infants, plus those gathered from Arm 1 and Arm 2, we will extract pose data from single-camera video recordings and convert these into kinematic features and relevant scores needed to classify infant movement. Receives: Other: Mobile App |
What is being measured
The primary outcome is the main question the study is designed to answer.
Prechtl's General Movements Assessment (GMA) score
The spontaneous movements of infants aged 1 to 5 months will be classified with the GMA. The GMA is a qualitative observational scale of infant movement. Normal infant movement is described as a writhing movement at earlier ages, characterized by small, circular and elegant movements, and fidgety movements at older ages.
Measured: 1 months
Prechtl's General Movements Assessment (GMA) score
The spontaneous movements of infants aged 1 to 5 months will be classified with the GMA. The GMA is a qualitative observational scale of infant movement. Normal infant movement is described as a writhing movement at earlier ages, characterized by small, circular and elegant movements, and fidgety movements at older ages.
Measured: 2 months
Prechtl's General Movements Assessment (GMA) score
The spontaneous movements of infants aged 1 to 5 months will be classified with the GMA. The GMA is a qualitative observational scale of infant movement. Normal infant movement is described as a writhing movement at earlier ages, characterized by small, circular and elegant movements, and fidgety movements at older ages.
Measured: 3 months
Prechtl's General Movements Assessment (GMA) score
The spontaneous movements of infants aged 1 to 5 months will be classified with the GMA. The GMA is a qualitative observational scale of infant movement. Normal infant movement is described as a writhing movement at earlier ages, characterized by small, circular and elegant movements, and fidgety movements at older ages.
Measured: 4 months
Prechtl's General Movements Assessment (GMA) score
The spontaneous movements of infants aged 1 to 5 months will be classified with the GMA. The GMA is a qualitative observational scale of infant movement. Normal infant movement is described as a writhing movement at earlier ages, characterized by small, circular and elegant movements, and fidgety movements at older ages.
Measured: 5 months
The Test of Infant Motor Performance (TIMP) score
The TIMP, a test of infant movement designed to be used at term age and up to 16 weeks after, will be used to assess infants between 0 and 4 months.
Measured: 1 month
The Test of Infant Motor Performance (TIMP) score
The TIMP, a test of infant movement designed to be used at term age and up to 16 weeks after, will be used to assess infants between 0 and 4 months.
Measured: 2 months
The Test of Infant Motor Performance (TIMP) score
The TIMP, a test of infant movement designed to be used at term age and up to 16 weeks after, will be used to assess infants between 0 and 4 months.
Measured: 3 months
The Test of Infant Motor Performance (TIMP) score
The TIMP, a test of infant movement designed to be used at term age and up to 16 weeks after, will be used to assess infants between 0 and 4 months.
Measured: 4 months
Alberta Infant Motor Scale (AIMS) score
The AIMS is a quick motor screen that will be administered with infants 3,6 months of age.
Measured: 3 months
Alberta Infant Motor Scale (AIMS) score
The AIMS is a quick motor screen that will be administered with infants 3,6 months of age.
Measured: 4 months
Alberta Infant Motor Scale (AIMS) score
The AIMS is a quick motor screen that will be administered with infants 3,6 months of age.
Measured: 5 months
Alberta Infant Motor Scale (AIMS) score
The AIMS is a quick motor screen that will be administered with infants 3,6 months of age.
Measured: 6 months
Hammersmith Infant Neurological Examination (HINE) score
The HINE, an examination of general infant neurological function and movement, will be administered with infants at all ages.
Measured: 1 months
Hammersmith Infant Neurological Examination (HINE) score
The HINE, an examination of general infant neurological function and movement, will be administered with infants at all ages.
Measured: 2 months
Hammersmith Infant Neurological Examination (HINE) score
The HINE, an examination of general infant neurological function and movement, will be administered with infants at all ages.
Measured: 3 months
Hammersmith Infant Neurological Examination (HINE) score
The HINE, an examination of general infant neurological function and movement, will be administered with infants at all ages.
Measured: 4 months
Hammersmith Infant Neurological Examination (HINE) score
The HINE, an examination of general infant neurological function and movement, will be administered with infants at all ages.
Measured: 5 months
Ability to predict The Hammersmith Infant Neurological Examination (HINE) score
The regression R-squared resulting from regression algorithm to predict the Test of Infant Motor Performance (TIMP)
Measured: 6 months
Ability to predict The Test of Infant Motor Performance (TIMP) score
The regression R-squared resulting from regression algorithm to predict the Test of Infant Motor Performance (TIMP)
Measured: 6 months
Ability to predict the Alberta Infant Motor Scale (AIMS) score
The regression R-squared resulting from a regression algorithm to predict the Alberta Infant Motor Scale (AIMS) score
Measured: 6 months
Secondary outcomes (6)
Average Path Length
The average path length of the center of pressure during a 2 minute session on the mat
Measured: 1 month
Average Path Length
The average path length of the center of pressure during a 2 minute session on the mat
Measured: 6 months
Toy contact time
Average voluntary contact time with the Toy - including sum of contact time with each arm and each leg
Measured: 1 month
Toy contact time
Average voluntary contact time with the Toy - including sum of contact time with each arm and each leg
Measured: 6 months
Toy contact frequency
Average # of voluntary contacts with the Toy - mean of with each arm and each leg
Measured: 1 month
Toy contact frequency
Average # of voluntary contacts with the Toy - mean of with each arm and each leg
Measured: 6 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Mar 2020
- Study start1 Nov 2020
- Primary completion27 Oct 2025
- Study completion27 Oct 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for Pediatric ALLStudies of the same condition, open and under way.
- More trials run by University of PennsylvaniaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 166 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Pennsylvania
- Sponsor type
- University, hospital or other
- Collaborators
- Children's Hospital of Philadelphia, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Responsible party
- Sponsor
- Investigators
- Michelle J Johnson, PhD, Principal investigator, The University of Pennsylvania
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04321200
- Sponsor's protocol ID
- 833180
- Other IDs
- R01HD097686
- Status last verified
- Aug 2026
- First submitted
- 17 Dec 2019
- Last updated
- 10 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Novak I, McIntyre S, Morgan C, Campbell L, Dark L, Morton N, Stumbles E, Wilson SA, Goldsmith S. A systematic review of interventions for children with cerebral palsy: state of the evidence. Dev Med Child Neurol. 2013 Oct;55(10):885-910. doi: 10.1111/dmcn.12246. Epub 2013 Aug 21.
PubMed 23962350Noble Y, Boyd R. Neonatal assessments for the preterm infant up to 4 months corrected age: a systematic review. Dev Med Child Neurol. 2012 Feb;54(2):129-39. doi: 10.1111/j.1469-8749.2010.03903.x. Epub 2011 Dec 5.
PubMed 22142216Einspieler C, Bos AF, Libertus ME, Marschik PB. The General Movement Assessment Helps Us to Identify Preterm Infants at Risk for Cognitive Dysfunction. Front Psychol. 2016 Mar 22;7:406. doi: 10.3389/fpsyg.2016.00406. eCollection 2016.
PubMed 27047429Rydz D, Shevell MI, Majnemer A, Oskoui M. Developmental screening. J Child Neurol. 2005 Jan;20(1):4-21. doi: 10.1177/08830738050200010201.
PubMed 15791916
Study at a glance
From the registry record, last updated by the sponsor on 10 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
- ClinicalTrials.gov ID
- NCT04321200
- Acronym / sponsor ID
- 833180
- Keywords
- Infants, Neurodevelopment, Developmental Delays, Electronics, Early Intervention, Sensory and Motor, NICU, Natural Play
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 166 participants (actual)
- Lead sponsor
- University of PennsylvaniaUniversity, hospital or other
- Collaborators
- Children's Hospital of Philadelphia, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Study start
- 1 Nov 2020 (actual)
- Primary completion
- 27 Oct 2025 (actual)
- Study completion
- 27 Oct 2025 (actual)
- First posted
- 25 Mar 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Early childhood detection of motor delays or impairments provides the opportunity for early treatment which improves health outcomes. This study will use state of the art sensors combined with machine learning algorithms to develop objective, accurate, easy-to-use tools for the early scoring of deficits and lays the foundation for the early prediction of physical disability.
Detailed description
For children with neurodevelopmental disabilities, early treatment in the first year of life improves long-term outcomes. However, the investigators are currently held back by inadequacies of available clinical tests to measure and predict impairment. Existing tests are hard to administer, require specialized training, and have limited long-term predictive value. There is a critical need to develop an objective, accurate, easy-to-use tool for the early prediction of long-term physical disability. The field of pediatrics and infant development would greatly benefit from a quantitative score that would correlate with existing clinical measures used today to detect movement impairments in very young infants. To realize a new generation of tests that will be easy to administer, the investigators will obtain large datasets of infants playing in an instrumented gym or simply being recorded while moving in a supine posture. Video and sensor data analyses will convert movement into feature vectors based on our knowledge of the problem domain. Our approach will use machine learning to relate these feature vectors to currently recommended clinical tests or other ground truth information. The power of this design is that algorithms can utilize many aspects of movement to produce the relevant scores.
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Cross-sectional-150 infants (atypical vs typical) | – | Diagnostic Test: PANDA GymArm (Study)1: To assess the concurrent validity of a multimodal instrumented gym with existing clinical tools. Here, using 150 infants, we will focus on converting data from an instrumented gym into estimates of the standard clinical tests. |
| Longitudinal cohort - 50 infants (atypical vs typical) | – | Diagnostic Test: PANDA GymArm (Study) 2: To discover the features related to long-term motor development. Here we will convert data collected longitudinally from 50 infants, using both instrumented gym and video recordings, into estimates standard clinical tests change over time and track features over developmental timescales. |
| Cross-sectional-1500 infants (atypical vs typical) | – | Other: Mobile AppArm (Study) 3: To develop a computer vision-based algorithm to quantify infant motor performance from a single-camera video. Here using video data from 1200 infants, plus those gathered from Arm 1 and Arm 2, we will extract pose data from single-camera video recordings and convert these into kinematic features and relevant scores needed to classify infant movement. |
Who may qualify
- Ages
- 0 to 6 months
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
- Study population
- Study 1: 150 infants (75 with early brain injury, 75 Control). Age 1-6 months. Study 2: 50 infants (25 with early brain injury, 25 Control). Age 1 month. Study 3: 1200 infants (400 with EBI, 400 preterm without EBI/risk for future disability, 400 controls) from video data. Age 1-6 months. Infants without EBI/risk for future disability: Infants without known brain injuries, but with a history of preterm birth less than 32 week gestation, significant medical problems, difficulty eating, or who lack head control at 4 months of age or later will be classified as moderate risk.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| PANDA GymInfants will lie supine on a flat surface and will be placed in the PANDA gym where they either move by themselves or will interact with an instrumented toy. We will collect video, mat, and toy data from PANDA gym under two conditions: 1) infants playing supine without a toy and 2) infants reach, grasp and kick of the new PANDA toy. A test session will proceed as follows: The infant will be placed on his or her back at a predetermined position on the gym mat for the 2-minute no toy condition. Next, the toy will be given to the baby and adjusted for the infant to reach or kick. A caregiver will be seated at the head of the baby (out of a baby's sight) to provide comfort if needed. Testing will be done in NICU or at daycare or the rehabilitation robotics lab at University of Pennsylvania. | Diagnostic test | Cross-sectional-150 infants (atypical vs typical), Longitudinal cohort - 50 infants (atypical vs typical) |
| Mobile AppThe parent or legal guardian will be consented first via the virtual rounding mobile app. They will also be asked to fill out general surveys including, a demographic survey, and a case report form, and a user feedback survey that provides relevant information, on both the family's and infant's medical history and experience. (see the flow-chart for the app). Within the caregiver survey, we will request the pediatrician (or primary care physician) name. We believe that with the baby name, caregiver name, zip code, and physician name, we will be able to locate the physician if needed. Parents or legal guardians or the research will be asked to collect video via the MOBILE app. They will be instructed to ensure that the infant lies supine in no more than one-layer of tight-fitting clothing (i.e. infant onesie) while calm and awake. In all cases, we will have video recordings of the baby. They will be asked to upload the video to the app. | Other | Cross-sectional-1500 infants (atypical vs typical) |
Primary outcome
Prechtl's General Movements Assessment (GMA) score
Time frame: 1 months
The spontaneous movements of infants aged 1 to 5 months will be classified with the GMA. The GMA is a qualitative observational scale of infant movement. Normal infant movement is described as a writhing movement at earlier ages, characterized by small, circular and elegant movements, and fidgety movements at older ages.
Prechtl's General Movements Assessment (GMA) score
Time frame: 2 months
The spontaneous movements of infants aged 1 to 5 months will be classified with the GMA. The GMA is a qualitative observational scale of infant movement. Normal infant movement is described as a writhing movement at earlier ages, characterized by small, circular and elegant movements, and fidgety movements at older ages.
Prechtl's General Movements Assessment (GMA) score
Time frame: 3 months
The spontaneous movements of infants aged 1 to 5 months will be classified with the GMA. The GMA is a qualitative observational scale of infant movement. Normal infant movement is described as a writhing movement at earlier ages, characterized by small, circular and elegant movements, and fidgety movements at older ages.
Prechtl's General Movements Assessment (GMA) score
Time frame: 4 months
The spontaneous movements of infants aged 1 to 5 months will be classified with the GMA. The GMA is a qualitative observational scale of infant movement. Normal infant movement is described as a writhing movement at earlier ages, characterized by small, circular and elegant movements, and fidgety movements at older ages.
Prechtl's General Movements Assessment (GMA) score
Time frame: 5 months
The spontaneous movements of infants aged 1 to 5 months will be classified with the GMA. The GMA is a qualitative observational scale of infant movement. Normal infant movement is described as a writhing movement at earlier ages, characterized by small, circular and elegant movements, and fidgety movements at older ages.
The Test of Infant Motor Performance (TIMP) score
Time frame: 1 month
The TIMP, a test of infant movement designed to be used at term age and up to 16 weeks after, will be used to assess infants between 0 and 4 months.
The Test of Infant Motor Performance (TIMP) score
Time frame: 2 months
The TIMP, a test of infant movement designed to be used at term age and up to 16 weeks after, will be used to assess infants between 0 and 4 months.
The Test of Infant Motor Performance (TIMP) score
Time frame: 3 months
The TIMP, a test of infant movement designed to be used at term age and up to 16 weeks after, will be used to assess infants between 0 and 4 months.
The Test of Infant Motor Performance (TIMP) score
Time frame: 4 months
The TIMP, a test of infant movement designed to be used at term age and up to 16 weeks after, will be used to assess infants between 0 and 4 months.
Alberta Infant Motor Scale (AIMS) score
Time frame: 3 months
The AIMS is a quick motor screen that will be administered with infants 3,6 months of age.
Alberta Infant Motor Scale (AIMS) score
Time frame: 4 months
The AIMS is a quick motor screen that will be administered with infants 3,6 months of age.
Alberta Infant Motor Scale (AIMS) score
Time frame: 5 months
The AIMS is a quick motor screen that will be administered with infants 3,6 months of age.
Alberta Infant Motor Scale (AIMS) score
Time frame: 6 months
The AIMS is a quick motor screen that will be administered with infants 3,6 months of age.
Hammersmith Infant Neurological Examination (HINE) score
Time frame: 1 months
The HINE, an examination of general infant neurological function and movement, will be administered with infants at all ages.
Hammersmith Infant Neurological Examination (HINE) score
Time frame: 2 months
The HINE, an examination of general infant neurological function and movement, will be administered with infants at all ages.
Hammersmith Infant Neurological Examination (HINE) score
Time frame: 3 months
The HINE, an examination of general infant neurological function and movement, will be administered with infants at all ages.
Hammersmith Infant Neurological Examination (HINE) score
Time frame: 4 months
The HINE, an examination of general infant neurological function and movement, will be administered with infants at all ages.
Hammersmith Infant Neurological Examination (HINE) score
Time frame: 5 months
The HINE, an examination of general infant neurological function and movement, will be administered with infants at all ages.
Ability to predict The Hammersmith Infant Neurological Examination (HINE) score
Time frame: 6 months
The regression R-squared resulting from regression algorithm to predict the Test of Infant Motor Performance (TIMP)
Ability to predict The Test of Infant Motor Performance (TIMP) score
Time frame: 6 months
The regression R-squared resulting from regression algorithm to predict the Test of Infant Motor Performance (TIMP)
Ability to predict the Alberta Infant Motor Scale (AIMS) score
Time frame: 6 months
The regression R-squared resulting from a regression algorithm to predict the Alberta Infant Motor Scale (AIMS) score
6 secondary outcomes
Average Path Length
Time frame: 1 month
Average Path Length
Time frame: 6 months
Toy contact time
Time frame: 1 month
Toy contact time
Time frame: 6 months
Toy contact frequency
Time frame: 1 month
Toy contact frequency
Time frame: 6 month
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Aug 2026.
- Background: PubMed 23962350Novak I, McIntyre S, Morgan C, Campbell L, Dark L, Morton N, Stumbles E, Wilson SA, Goldsmith S. A systematic review of interventions for children with cerebral palsy: state of the evidence. Dev Med Child Neurol. 2013 Oct;55(10):885-910. doi: 10.1111/dmcn.12246. Epub 2013 Aug 21.
- Background: PubMed 22142216Noble Y, Boyd R. Neonatal assessments for the preterm infant up to 4 months corrected age: a systematic review. Dev Med Child Neurol. 2012 Feb;54(2):129-39. doi: 10.1111/j.1469-8749.2010.03903.x. Epub 2011 Dec 5.
- Background: PubMed 27047429Einspieler C, Bos AF, Libertus ME, Marschik PB. The General Movement Assessment Helps Us to Identify Preterm Infants at Risk for Cognitive Dysfunction. Front Psychol. 2016 Mar 22;7:406. doi: 10.3389/fpsyg.2016.00406. eCollection 2016.
- Background: PubMed 15791916Rydz D, Shevell MI, Majnemer A, Oskoui M. Developmental screening. J Child Neurol. 2005 Jan;20(1):4-21. doi: 10.1177/08830738050200010201.
- Individual participant dataSharing planned: Undecided
Related trials for Pediatric ALL
Not yet recruitingPhase 1/2
A Study of Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia
Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
Not yet recruiting
The Contribution of Accelerated Recovery (mERAS) Approach to Postoperative Recovery in Pediatric Laparoscopic Surgery Cases
mERAS Intervention, The ASA (American Society of Anesthesiologists) Score
Recruiting
Amnioinfusion's Protective Effects on Respiratory and Longitudinal Pediatric Outcomes After Intrapartum Meconium Exposure
Neonatal Respiratory Distress Related Conditions, Meconium
Not yet recruitingObservational study
Multimodal Mechanical, Tissue, Architectural, and Histological Evaluation of the Bone and Sutures of the Parietal Bone in an Infant With Craniosynostosis.
Craniostenosis
Recruiting
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
Cerebral Palsy, Muscular Dystrophy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Michelle J Johnson, PhD principal investigator
The University of Pennsylvania
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pediatric ALL and Infant Development, run by University of Pennsylvania at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 10 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prechtl's General Movements Assessment (GMA) score (time frame: 1 months). The study lists 21 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04321200, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Aug 2026.